Startups
Targeting escape mutations in hematological cancers with first and best in class medicines.
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Lomond Therapeutics | “Targeting escape mutations in hematological cancers with first and best in class medicines.” |
Reviews 0
FAQ about Lomond Therapeutics
What has the press written about Lomond Therapeutics?
Parsers VC has collected 2 articles mentioning Lomond Therapeutics, among them “Lomond Therapeutics”.
Is Lomond Therapeutics still active?
Yes, Lomond Therapeutics is active; its latest activity on Parsers VC dates from Aug 5, 2025.